Found: 31
Select item for more details and to access through your institution.
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1, doi. 10.1111/dom.15067
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1141, doi. 10.1111/dom.14752
- Publication type:
- Article
Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1143, doi. 10.1111/dom.14963
- By:
- Publication type:
- Article
The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1147, doi. 10.1111/dom.14980
- By:
- Publication type:
- Article
Detecting and treating the protean manifestations of diabetic autonomic neuropathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1162, doi. 10.1111/dom.15004
- By:
- Publication type:
- Article
Anagliptin twice‐daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double‐blind, randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1174, doi. 10.1111/dom.14959
- By:
- Publication type:
- Article
Exercise‐related hypoglycaemia induces QTc‐interval prolongation in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1186, doi. 10.1111/dom.14964
- By:
- Publication type:
- Article
Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1196, doi. 10.1111/dom.14966
- By:
- Publication type:
- Article
A microbiome‐targeting fibre‐enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1203, doi. 10.1111/dom.14967
- By:
- Publication type:
- Article
Liver‐expressed antimicrobial peptide 2 is associated with improved pancreatic insulin secretion in adults with overweight and obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1213, doi. 10.1111/dom.14968
- By:
- Publication type:
- Article
Efficacy and safety of basal‐first titration order in individuals with type 2 diabetes receiving short‐term intensive insulin therapy: An exploratory analysis of BEYOND V.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1221, doi. 10.1111/dom.14970
- By:
- Publication type:
- Article
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1229, doi. 10.1111/dom.14971
- By:
- Publication type:
- Article
A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1241, doi. 10.1111/dom.14972
- By:
- Publication type:
- Article
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1249, doi. 10.1111/dom.14974
- By:
- Publication type:
- Article
Joint longitudinal and time‐to‐event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1261, doi. 10.1111/dom.14975
- By:
- Publication type:
- Article
Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1271, doi. 10.1111/dom.14976
- By:
- Publication type:
- Article
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double‐blind placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1280, doi. 10.1111/dom.14977
- By:
- Publication type:
- Article
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1292, doi. 10.1111/dom.14979
- By:
- Publication type:
- Article
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1301, doi. 10.1111/dom.14981
- By:
- Publication type:
- Article
Identifying diabetogenic drugs using real world health care databases: A Danish and Australian symmetry analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1311, doi. 10.1111/dom.14982
- By:
- Publication type:
- Article
Effects of co‐ingesting glucose and whey protein on blood glucose, plasma insulin and glucagon concentrations, and gastric emptying, in older men with and without type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1321, doi. 10.1111/dom.14983
- By:
- Publication type:
- Article
Therapeutic inertia related to the injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1331, doi. 10.1111/dom.14985
- By:
- Publication type:
- Article
Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1341, doi. 10.1111/dom.14986
- By:
- Publication type:
- Article
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1351, doi. 10.1111/dom.14987
- By:
- Publication type:
- Article
Meta‐analysis of head‐to‐head clinical trials comparing incretin‐based glucose‐lowering medications and basal insulin: An update including recently developed glucagon‐like peptide‐1 (GLP‐1) receptor agonists and the glucose‐dependent insulinotropic polypeptide/GLP‐1 receptor co‐agonist tirzepatide
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1361, doi. 10.1111/dom.14988
- By:
- Publication type:
- Article
Cardiovascular outcomes trial data from EMPA‐REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1372, doi. 10.1111/dom.14989
- By:
- Publication type:
- Article
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1385, doi. 10.1111/dom.14990
- By:
- Publication type:
- Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
- By:
- Publication type:
- Article
Beta‐cell function in treatment‐naïve patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1403, doi. 10.1111/dom.14969
- By:
- Publication type:
- Article
Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross‐sectional survey.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1408, doi. 10.1111/dom.14973
- By:
- Publication type:
- Article
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978
- By:
- Publication type:
- Article